ARE THERE CHANGES IN SENSITIVITY TO 5-HT3 RECEPTOR LIGANDS FOLLOWING CHRONIC DIAZEPAM TREATMENT

被引:29
作者
ANDREWS, N [1 ]
FILE, SE [1 ]
机构
[1] UNITED MED & DENT SCH GUYS & ST THOMAS HOSP,GUYS HOSP,DIV PHARMACOL,PSYCHOPHARMACOL RES UNIT,LONDON SE1 9RT,ENGLAND
基金
英国惠康基金;
关键词
BENZODIAZEPINE; DEPENDENCE; ANXIETY; 5-HT3; ZACOPRIDE;
D O I
10.1007/BF02245120
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Administration of 1-(3-chlorophenyl)-biguanide (mCPB), a 5-HT3 receptor agonist (1 and 10 mg/kg IP), was found to be significantly anxiogenic in vehicle treated rats tested in the plus-maze, while having no significant effect in rats withdrawn for 24 h from 21 days diazepam treatment (2 mg/kg/day), suggesting a decreased agonist action at 5-HT3 receptors following withdrawal from chronic diazepam treatment. In the social interaction test, diazepam withdrawn rats showed a significant decrease in social interaction when compared to the chronic vehicle treated group. This anxiogenic response was reversed by low doses of zacopride (0.0001-0.01 mg/kg IP); in the vehicle treated animals 0.1 mg/kg was significantly anxiogenic. The overall pattern of results with zacopride is explained by suggesting that the anxiogenic effects of high doses of zacopride are detectable at low levels of 5-HT function and are due to an agonist action of the S-isomer in the rat at 5-HT3 receptors. The anxiolytic action of low doses is attributed to the R-isomer acting at the R-zacopride binding site and is enhanced in conditions of high 5-HT function, e.g. in the diazepam withdrawn rats. If this hypothesis is correct, then we would predict the R-isomer alone would be more effective in reversing the anxiogenic effects of diazepam withdrawal than the racemate, used here.
引用
收藏
页码:333 / 337
页数:5
相关论文
共 27 条
  • [1] ANDREWS MA, 1992, IN PRESS PHARM BIOCH
  • [2] THE DIFFERENTIAL ACTIVITIES OF R(+)-ZACOPRIDE AND S(-)-ZACOPRIDE AS 5-HT3 RECEPTOR ANTAGONISTS
    BARNES, JM
    BARNES, NM
    COSTALL, B
    DOMENEY, AM
    JOHNSON, DN
    KELLY, ME
    MUNSON, HR
    NAYLOR, RJ
    YOUNG, R
    [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1990, 37 (04) : 717 - 727
  • [3] [H-3] ZACOPRIDE - LIGAND FOR THE IDENTIFICATION OF 5-HT3 RECOGNITION SITES
    BARNES, NM
    COSTALL, B
    NAYLOR, RJ
    [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 1988, 40 (08) : 548 - 551
  • [4] PRELIMINARY EVIDENCE FOR THE INVOLVEMENT OF THE PUTATIVE 5-HT4 RECEPTOR IN ZACOPRIDE-INDUCED AND COPPER SULFATE-INDUCED VOMITING IN THE FERRET
    BHANDARI, P
    ANDREWS, PLR
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1991, 204 (03) : 273 - 280
  • [5] (-) BACLOFEN DECREASES NEUROTRANSMITTER RELEASE IN THE MAMMALIAN CNS BY AN ACTION AT A NOVEL GABA RECEPTOR
    BOWERY, NG
    HILL, DR
    HUDSON, AL
    DOBLE, A
    MIDDLEMISS, DN
    SHAW, J
    TURNBULL, M
    [J]. NATURE, 1980, 283 (5742) : 92 - 94
  • [6] ACTIVATION OF 5-HT3 RECEPTOR BY 1-PHENYLBIGUANIDE INCREASES DOPAMINE RELEASE IN THE RAT NUCLEUS-ACCUMBENS
    CHEN, J
    VANPRAAG, HM
    GARDNER, EL
    [J]. BRAIN RESEARCH, 1991, 543 (02) : 354 - 357
  • [7] EFFECTS OF THE 5-HT3 RECEPTOR ANTAGONIST, GR38032F, ON RAISED DOPAMINERGIC ACTIVITY IN THE MESOLIMBIC SYSTEM OF THE RAT AND MARMOSET BRAIN
    COSTALL, B
    DOMENEY, AM
    NAYLOR, RJ
    TYERS, MB
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1987, 92 (04) : 881 - 894
  • [8] ZACOPRIDE - ANXIOLYTIC PROFILE IN RODENT AND PRIMATE MODELS OF ANXIETY
    COSTALL, B
    DOMENEY, AM
    GERRARD, PA
    KELLY, ME
    NAYLOR, RJ
    [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 1988, 40 (04) : 302 - 305
  • [9] THE EFFECTS OF ONDANSETRON (GR38032F) IN RATS AND MICE TREATED SUBCHRONICALLY WITH DIAZEPAM
    COSTALL, B
    JONES, BJ
    KELLY, ME
    NAYLOR, RJ
    OAKLEY, NR
    ONAIVI, ES
    TYERS, MB
    [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1989, 34 (04) : 769 - 778
  • [10] PATTERNS OF BENZODIAZEPINE USE IN GREAT-BRITAIN AS MEASURED BY A GENERAL-POPULATION SURVEY
    DUNBAR, GC
    PERERA, MH
    JENNER, FA
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 1989, 155 : 836 - 841